AbCellera Biologics Inc.
ABCL | NASDAQ
$12.66
+$0.03 (+0.24%)
At close: Sep 21, 2026, 4:00 PM ET
$12.61
-$0.05 (-0.39%)
Pre-market:
Sep 22, 2026, 6:17 AM ET
Market Data
Market Cap $3.87B
Enterprise Value $3.46B
Beta 1.19
Average Volume 8.04M
Shares Outstanding (Diluted) 305.56M
Shares Change YoY 2.36%
Institutional Ownership 41.01%
Exchange NASDAQ
ISIN CA00288U1066
Price Performance
Price Change 1M 15.9%
Price Change 3M 124.9%
Price Change 6M 273.4%
Price Change YTD 269.1%
Price Change 1Y 162.1%
Price Change 3Y 153.2%
Price Change 5Y -40.1%
1M CAGR (ann.) 82.7%
1Y CAGR (ann.) 168.2%
5Y CAGR (ann.) -6.5%
All-Time CAGR -23.4%
Valuation
PE Ratio -23.44
Forward PE N/A
PEG Ratio 43.16
Forward PEG -2.52
PS Ratio 58.42
Forward PS 148.40
PB Ratio 4.31
P/FCF Ratio -21.54
P/Adj. FCF Ratio -16.77
P/OCF Ratio -24.82
EV/Sales 52.31
EV/EBIT -17.17
EV/EBITDA -21.59
EV/FCF -19.29
Earnings Yield -4.3%
FCF Yield -4.6%
Adj. FCF Yield -6.0%
Financial Health
Net Cash $540.1M
Total Debt $135.62M
Cash & Short-Term Investments $540.1M
Total Assets $1.31B
Current Ratio 12.77
Quick Ratio 12.63
Debt / Equity Ratio 0.15
Debt / EBITDA -0.85
Debt / FCF -0.76
OCF / Debt -1.14
Interest Coverage 0.00
Altman Z-Score 5.62
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 75.0%
Operating Profit Margin -340.3%
EBITDA Margin -242.3%
Net Profit Margin -248.8%
FCF Margin -271.2%
Adj. FCF Margin -348.4%
SBC / Revenue 77.2%
SBC Impact (per share) -28.5%
Returns
Return on Assets -12.6%
Return on Equity -17.5%
Return on Invested Capital -14.9%
Return on Capital Employed -17.9%
Return on Tangible Assets -13.5%
Historical Growth (CAGR)
Revenue CAGR 3Y -23.0%
Revenue CAGR 5Y -31.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -0.9%
EPS CAGR 5Y -103.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y -3.0%
FCF CAGR 5Y -113.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 12
EPS Growth Next 3Y -16.1%
Revenue Growth Next 3Y -4.5%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) -$0.18
EPS Growth Est (next Q) -5.3%
Revenue Est (next Q) $5.32M
Revenue Growth Est (next Q) -40.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $15.33
Price Target Upside 21.1%
Cash Flow
Operating Cash Flow $-154.72M
Free Cash Flow $-179.46M
Adj. Free Cash Flow $-230.56M
FCF Per Share -$0.59
OCF Per Share -$0.51
OCF/S Ratio -233.8%
Income Statement
Revenue $66.17M
Gross Profit $49.6M
Operating Income $-225.16M
EBITDA $-160.3M
Net Income $-164.66M
EPS (Diluted) -$0.54
Revenue / Employee $117.75K
Profit / Employee $-292.98K
Employees 562
Add to Watchlist
Select watchlists to add or remove ABCL